 |
PDBsum entry 1i92
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1i92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:19683-19686
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator.
|
|
S.Karthikeyan,
T.Leung,
J.A.Ladias.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The PDZ1 domain of the Na(+)/H(+) exchanger regulatory factor (NHERF) binds with
nanomolar affinity to the carboxyl-terminal sequence QDTRL of the cystic
fibrosis transmembrane conductance regulator (CFTR) and plays a central role in
the cellular localization and physiological regulation of this chloride channel.
The crystal structure of human NHERF PDZ1 bound to the carboxyl-terminal peptide
QDTRL has been determined at 1.7-A resolution. The structure reveals the
specificity and affinity determinants of the PDZ1-CFTR interaction and provides
insights into carboxyl-terminal leucine recognition by class I PDZ domains. The
peptide ligand inserts into the PDZ1 binding pocket forming an additional
antiparallel beta-strand to the PDZ1 beta-sheet, and an extensive network of
hydrogen bonds and hydrophobic interactions stabilize the complex. Remarkably,
the guanido group of arginine at position -1 of the CFTR peptide forms two salt
bridges and two hydrogen bonds with PDZ1 residues Glu(43) and Asn(22),
respectively, providing the structural basis for the contribution of the
penultimate amino acid of the peptide ligand to the affinity of the interaction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of the NHERF PDZ1 domain bound to the
CFTR sequence QDTRL. A, sequence comparison of PDZ domains that
bind to CFTR. The indicated PDZ domains from human NHERF (5),
human NHERF2 (8), and murine PDZK1/CAP70 (12) were aligned using
MACAW (36). Absolutely conserved residues are shown as white
letters on blue background. Identical residues in four domains
are shaded in cyan. The secondary structure of NHERF PDZ1 is
indicated at the top. Conserved acidic residues proposed to
interact with Arg 1 of the
CFTR ligand are denoted by an asterisk. B, stereo view of the
NHERF PDZ1 crystal packing. Each carboxyl terminus serves as a
ligand for a neighboring PDZ1 molecule. C, ribbon diagram of the
NHERF PDZ1 domain bound to the QDTRL peptide. The strands 1- 6 are shown
in yellow, and the helices 1 and 2 are shown
in green. The peptide ligand QDTRL is shown in pink. The figure
was made using MOLSCRIPT (37) and Raster3D (38). D, surface
topology of the NHERF PDZ1 bound to the peptide QDTRL. The
figure was generated using GRASP (39).
|
 |
Figure 2.
Fig. 2. NHERF PDZ1 interactions with the peptide QDTRL.
A, stereo view of a 2F[obs] F[calc]
electron density map calculated at 1.7-Å resolution and
contoured at 1 at the
peptide-binding site. B, stereo image of the NHERF PDZ1 binding
pocket bound to the carboxyl-terminal peptide ligand (gray).
Carbon, oxygen, and nitrogen atoms are shown in black, red, and
blue, respectively. Water molecules are shown as red spheres and
hydrogen bonds as dashed lines. C, two-dimensional
representation of the interactions observed between the NHERF
PDZ1 residues (orange) and the peptide ligand (purple). Dashed
lines denote hydrogen bonds, and numbers indicate hydrogen bond
lengths in Å. Hydrophobic interactions are shown as arcs
with radial spokes. The figure was made using LIGPLOT (40).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
19683-19686)
copyright 2001.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Ernst,
D.Gfeller,
Z.Kan,
S.Seshagiri,
P.M.Kim,
G.D.Bader,
and
S.S.Sidhu
(2010).
Coevolution of PDZ domain-ligand interactions analyzed by high-throughput phage display and deep sequencing.
|
| |
Mol Biosyst,
6,
1782-1790.
|
 |
|
|
|
|
 |
S.Kalyoncu,
O.Keskin,
and
A.Gursoy
(2010).
Interaction prediction and classification of PDZ domains.
|
| |
BMC Bioinformatics,
11,
357.
|
 |
|
|
|
|
 |
H.Cheng,
J.Li,
R.Fazlieva,
Z.Dai,
Z.Bu,
and
H.Roder
(2009).
Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1.
|
| |
Structure,
17,
660-669.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Li,
D.J.Callaway,
and
Z.Bu
(2009).
Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1.
|
| |
J Mol Biol,
392,
166-180.
|
 |
|
|
|
|
 |
M.Bajmoczi,
M.Gadjeva,
S.L.Alper,
G.B.Pier,
and
D.E.Golan
(2009).
Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa.
|
| |
Am J Physiol Cell Physiol,
297,
C263-C277.
|
 |
|
|
|
|
 |
U.Seidler,
A.K.Singh,
A.Cinar,
M.Chen,
J.Hillesheim,
B.Hogema,
and
B.Riederer
(2009).
The role of the NHERF family of PDZ scaffolding proteins in the regulation of salt and water transport.
|
| |
Ann N Y Acad Sci,
1165,
249-260.
|
 |
|
|
|
|
 |
P.R.Cushing,
A.Fellows,
D.Villone,
P.Boisguérin,
and
D.R.Madden
(2008).
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
|
| |
Biochemistry,
47,
10084-10098.
|
 |
|
|
|
|
 |
C.S.Theisen,
J.K.Wahl,
K.R.Johnson,
and
M.J.Wheelock
(2007).
NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility.
|
| |
Mol Biol Cell,
18,
1220-1232.
|
 |
|
|
|
|
 |
C.Tandon,
R.C.De Lisle,
I.Boulatnikov,
and
P.K.Naik
(2007).
Interaction of carboxyl-terminal peptides of cytosolic-tail of apactin with PDZ domains of NHERF/EBP50 and PDZK-1/CAP70.
|
| |
Mol Cell Biochem,
302,
157-167.
|
 |
|
|
|
|
 |
J.Iwanczyk,
D.Damjanovic,
J.Kooistra,
V.Leong,
A.Jomaa,
R.Ghirlando,
and
J.Ortega
(2007).
Role of the PDZ domains in Escherichia coli DegP protein.
|
| |
J Bacteriol,
189,
3176-3186.
|
 |
|
|
|
|
 |
J.M.Elkins,
E.Papagrigoriou,
G.Berridge,
X.Yang,
C.Phillips,
C.Gileadi,
P.Savitsky,
and
D.A.Doyle
(2007).
Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions.
|
| |
Protein Sci,
16,
683-694.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Q.Chen,
X.Niu,
Y.Xu,
J.Wu,
and
Y.Shi
(2007).
Solution structure and backbone dynamics of the AF-6 PDZ domain/Bcr peptide complex.
|
| |
Protein Sci,
16,
1053-1062.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.T.Runyon,
Y.Zhang,
B.A.Appleton,
S.L.Sazinsky,
P.Wu,
B.Pan,
C.Wiesmann,
N.J.Skelton,
and
S.S.Sidhu
(2007).
Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3.
|
| |
Protein Sci,
16,
2454-2471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Sugi,
T.Oyama,
T.Muto,
S.Nakanishi,
K.Morikawa,
and
H.Jingami
(2007).
Crystal structures of autoinhibitory PDZ domain of Tamalin: implications for metabotropic glutamate receptor trafficking regulation.
|
| |
EMBO J,
26,
2192-2205.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Zhang,
B.A.Appleton,
P.Wu,
C.Wiesmann,
and
S.S.Sidhu
(2007).
Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain.
|
| |
Protein Sci,
16,
1738-1750.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Basdevant,
H.Weinstein,
and
M.Ceruso
(2006).
Thermodynamic basis for promiscuity and selectivity in protein-protein interactions: PDZ domains, a case study.
|
| |
J Am Chem Soc,
128,
12766-12777.
|
 |
|
|
|
|
 |
T.Sugiura,
Y.Kato,
Y.Kubo,
and
A.Tsuji
(2006).
Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
|
| |
Drug Metab Pharmacokinet,
21,
375-383.
|
 |
|
|
|
|
 |
W.R.Thelin,
C.A.Hodson,
and
S.L.Milgram
(2005).
Beyond the brush border: NHERF4 blazes new NHERF turf.
|
| |
J Physiol,
567,
13-19.
|
 |
|
|
|
|
 |
A.C.Hamilton,
J.Inglese,
and
M.Ferrer
(2003).
A PDZ domain-based assay for measuring HIV protease activity: assay design considerations.
|
| |
Protein Sci,
12,
458-467.
|
 |
|
|
|
|
 |
B.S.Kang,
D.R.Cooper,
Y.Devedjiev,
U.Derewenda,
and
Z.S.Derewenda
(2003).
Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm.
|
| |
Structure,
11,
845-853.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.C.Yun
(2003).
Concerted roles of SGK1 and the Na+/H+ exchanger regulatory factor 2 (NHERF2) in regulation of NHE3.
|
| |
Cell Physiol Biochem,
13,
29-40.
|
 |
|
|
|
|
 |
S.S.Sidhu,
W.J.Fairbrother,
and
K.Deshayes
(2003).
Exploring protein-protein interactions with phage display.
|
| |
Chembiochem,
4,
14-25.
|
 |
|
|
|
|
 |
V.Raghuram,
H.Hormuth,
and
J.K.Foskett
(2003).
A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions.
|
| |
Proc Natl Acad Sci U S A,
100,
9620-9625.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |